University of Miami has patented new vasopressin V1A receptor antagonists reported to be useful for the treatment of osteoporosis, Paget disease and cancer. BioWorld Science Endocrine/metabolic ...
Vasopressin is an inconvenient hormone to be without. When untreated, people lacking this nine-amino-acid peptide hormone (in central diabetes insipidus) or its target receptor (in X-linked ...
Objectives: To determine the effect of vasopressin therapy on the efficacy of oxygenation and arterial pressure in infants with severe persistent pulmonary hypertension of the newborn. Conclusions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback